Which DMARD for ICI-associated arthritis?

Nature Reviews Rheumatology, Published online: 22 May 2023; doi:10.1038/s41584-023-00983-9In a retrospective study, biologic DMARD therapy was associated with faster control of immune checkpoint inhibitor-associated arthritis but also with a shorter time to cancer progression, compared with methotrexate therapy.
Source: Nature Reviews Rheumatology - Category: Rheumatology Authors: Source Type: research